Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

GLIBEN-M

Class 5Status: Removed
Application Number1144491
Trademark Status
Removed
Trademark Class5
Application Date2002-10-18
Proprietor Name(1) PRG PHARMA PVT. LTD.Trading As : PRG PHARMA PVT. LTD.Body Incorporate
Appropriate OfficeDELHI
StateCHANDIGARH
Trademark TypeWORD
User Details01/10/2002
Goods And Services Details[CLASS : 5] MEDICINES.Associated Trademarks 1144490Publication Details Published in Journal No. : 9999-5     Dated : 14/11/2003

Identical Trademarks

Similar trademarks found for this brand

1 found
BrandClassStatus
GLIBEN-M5Removed
Showing up to 6 identical trademarksView more on LEDGERS→

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about GLIBEN M.

What is the status of trademark application 1144491?
The current status of trademark application 1144491 for GLIBEN-M is Removed.
What is the trademark class of GLIBEN-M?
GLIBEN-M is registered under trademark class 5.
Who is the proprietor of GLIBEN-M?
The proprietor of GLIBEN-M is (1) PRG PHARMA PVT. LTD.Trading As : PRG PHARMA PVT. LTD.Body Incorporate.
When was trademark application 1144491 filed?
Trademark application 1144491 for GLIBEN-M was filed on 2002-10-18.